Lanham O'Dell & Company, Inc. Merck & Co., Inc. Transaction History

Lanham O'Dell & Company, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $225,004 - $244,858	2,246 New	2,246 $244,000
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $42,408 - $54,373	485 Added 14.29%	3,880 $430,000
Q3 2022 Nov 08, 2022	BUY	$84.53 - $94.96 $84,699 - $95,149	1,002 Added 41.87%	3,395 $292,000
Q2 2022 Aug 09, 2022	BUY	$83.49 - $94.64 $199,791 - $226,473	2,393 New	2,393 $218,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Lanham O'Dell & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Lanham O'Dell & Company, Inc. with notifications on news.